Oral polio vaccine AIDS hypothesis

Last updated

The oral polio vaccine (OPV) AIDS hypothesis is a now-discredited hypothesis that the AIDS pandemic originated from live polio vaccines prepared in chimpanzee tissue cultures, accidentally contaminated with simian immunodeficiency virus and then administered to up to one million Africans between 1957 and 1960 in experimental mass vaccination campaigns.

Contents

Data analyses in molecular biology and phylogenetic studies contradict the OPV AIDS hypothesis; consequently, scientific consensus regards the hypothesis as disproven. [1] [2] [3] [4] A 2004 Nature article has described the hypothesis as "refuted". [5]

Background: polio vaccines

Two vaccines are used throughout the world to combat poliomyelitis. The first, a polio vaccine developed by Jonas Salk, is an inactivated poliovirus vaccine (IPV), consisting of a mixture of three wild, virulent strains of poliovirus, grown in a type of monkey kidney tissue culture (Vero cell line), and made noninfectious by formaldehyde treatment. The second vaccine, an oral polio vaccine (OPV), is a live-attenuated vaccine, produced by the passage of the virus through non-human cells at a sub-physiological temperature. The passage of virus produces mutations within the viral genome, and hinders the virus's ability to infect nervous tissue. [6]

Both vaccines have been used for decades to induce immunity to polio, and to stop the spread of the infection. However, OPV has several advantages; because the vaccine is introduced in the gastrointestinal tract, the primary site of poliovirus infection and replication, it closely mimics a natural infection. OPV also provides long lasting immunity, and stimulates the production of polio neutralizing antibodies in the pharynx and gut. [7] Hence, OPV not only prevents paralytic poliomyelitis, but also, when given in sufficient doses, can stop a threatening epidemic. Other benefits of OPV include ease of administration, low cost and suitability for mass vaccination campaigns. [6]

Oral polio vaccine

Oral polio vaccines were developed in the late 1950s by several groups, including those led by Albert Sabin, Hilary Koprowski and H. R. Cox. [8] A poliovirus type 1 strain called SM was reported in 1954. A less virulent version of the SM strain was reported by Koprowski in 1957. The name of the vaccine strain was "CHAT" after "Charlton", the name of the child who was the donor of the precursor virus. [9] The Sabin, Koprowski and Cox vaccines were clinically tested in millions of individuals and found to be safe and effective. Because monkey trials found fewer side effects with the Sabin vaccine, in the early 1960s, the Sabin vaccine was licensed in the US and its use supported by the World Health Organization. [8]

Between 1957 and 1960, Koprowski's vaccine was administered to roughly one million people in the Belgian territories, now the Democratic Republic of the Congo, Rwanda and Burundi. [9] In 1960, Koprowski wrote in the British Medical Journal, "The Belgian Congo trials have enlarged considerably and ... more vaccination campaigns organized in several provinces of the Belgian Congo are raising the number of vaccinated individuals into the millions."(p. 90) Koprowski and his group also published a series of detailed reports on the vaccination of 76,000 children under the age of five (and European adults) in the area of Leopoldville (now Kinshasa) in Belgian Congo from 1958 to 1960; these reports begin with an overview, [10] next a review of safety and efficacy, [11] then a 21-month follow-up and final report. [12]

Vaccine production

In the 1950s, before dangers inherent to the process were well controlled, seed stocks of vaccines were occasionally transported to distant regions, then standard tissue culture methods [13] [14] [15] were used to amplify the virus at local production facilities. Biologic products, chiefly kidney cells for cultures and blood serum for media, were sometimes harvested from local primates and used in the production process if wild or captive populations of appropriate species were available. [16] In South Africa, African green monkey tissue was used to amplify the Sabin vaccine. In French West Africa and Equatorial Africa, baboons were used to amplify a vaccine from the Pasteur Institute. In Poland, the CHAT vaccine was amplified using Asian macaques. [17]

Development of hypothesis

In 1987, Blaine Elswood contacted journalist Tom Curtis about a "bombshell story" on OPV and AIDS. Curtis published an article on the OPV AIDS hypothesis in Rolling Stone in 1992. [18] In response, Hilary Koprowski sued Rolling Stone and Tom Curtis for defamation. The magazine published a clarification which praised Koprowski and stated:

The editors of Rolling Stone wish to clarify that they never intended to suggest in the article that there is any scientific proof, nor do they know of any scientific proof, that Dr. Koprowski, an illustrious scientist, was in fact responsible for introducing AIDS to the human population or that he is the father of AIDS. [19]

Rolling Stone was ordered to pay US$1 in damages whilst incurring around US$500,000 in legal fees for its own defense. [20]

A few scientists, notably the evolutionary biologist W. D. Hamilton, thought the hypothesis required serious investigation, but they received little support from the scientific community. [21] For example, in 1996, Science refused to publish a letter Hamilton sent to it in which he replied to a 1992 Koprowski letter. [22] Hamilton kept his position and said in 1999, "This theory, rather sadly, has gone from strength to strength. It's not proven by any means, but it's looking very strong." [23] Hamilton was also supportive of journalist Edward Hooper who detailed the hypothesis in his 1999 book, The River. [22] Hamilton wrote the foreword for the book and did two expeditions to Congo between December 1999 and January 2000 to collect evidences on the OPV hypothesis. [24] None of the over 60 urine and faecal samples collected by Hamilton contained SIV. [21] Still, Hamilton used his prestige within the Royal Society to promote a discussion meeting about the OPV hypothesis. [22] In this meeting, held six months after Hamilton's death, in September 2000, [24] Hooper further expanded on his allegations, although these claims were later rebutted by some of the scientists who were present at the meeting. [25] In 2001, Hilary Koprowski responded by making a detailed rebuttal of the points made in the book, also in a talk to the Royal Society. [26] In 2004, the Origin of Aids, a French TV documentary strongly supportive of the OPV hypothesis, appeared on several television stations around the world. [27] [28]

The Laboratoire Medical de Stanleyville was sited at the city now known as Kisangani. Cg-map.png
The Laboratoire Médical de Stanleyville was sited at the city now known as Kisangani.

In 2003, Hooper published additional statements that he believed supported his hypothesis in an article in the London Review of Books . These included accounts of an interview with Jacques Kanyama, a virology technician at the lab in Stanleyville (the Laboratoire Médical de Stanleyville (LMS)) responsible for testing the CHAT vaccine and performing the initial set of vaccinations, who was reported to have said that batches of CHAT had been produced on site by Paul Osterrieth. In addition, Philip Elebe, a microbiology technician, was claimed to have said that tissue cultures were being produced from Lindi chimpanzees. Osterrieth has denied these claims and stated that this work would not have been possible in this laboratory, [29] [30] [17] stating that:

at no time did I ever attempt to make cell cultures from chimpanzee tissues. In addition, I wish to state categorically that no poliovaccine was ever produced or could have been produced in Stanleyville, since the facilities were totally inadequate for the production or control of poliovaccine. [17]

In his book, Hooper also stated that Gaston Ninane was involved in using chimpanzee cells to produce vaccine in Congo. Ninane responded to this allegation by stating that he could "categorically deny" ever having tried to make tissue cultures from chimpanzee cells. [9] The people involved in vaccine production and distribution from America state that no vaccine was prepared locally in Congo and that only the CHAT vaccine from America was used. Barbara Cohen, the technician who was responsible for running the American laboratory that produced this vaccine stated:

At no time did I ever receive or work on chimpanzee kidneys, nor to my knowledge cells derived from chimpanzees. I never made, nor do I know of anyone in the lab who made polio vaccine in chimpanzee cells. [17]

Scientific investigation

In an August 1992 letter published in Science, Koprowski repudiated the OPV AIDS hypothesis, pointing to multiple errors of fact in its assertions. [31] In October 1992, Science ran a story titled "Panel Nixes Congo Vaccine as AIDS source", describing the findings of an independent panel which found each proposed step in the OPV-AIDS hypothesis "problematic". The story concluded:

...it can be stated with almost complete certainty that the large polio vaccine trial... was not the origin of AIDS. [32]

The oldest confirmed sample of human tissue that shows the presence of HIV-1 is an archival sample of plasma collected from an anonymous donor in the city of Leopoldville, Belgian Congo (now Kinshasa, Democratic Republic of the Congo) in 1959 and was found with retrospective genetic analysis to be most closely related to subtype D strains. In 2008, partial HIV viral sequences were identified from a specimen of lymph node collected from an adult female, also in Kinshasa, in 1960. This specimen, named DRC60, was around 88% similar to ZR59, but was found to be most closely related to subtype A HIV-1 strains. These specimens are significant not only because they are the oldest specimens of the virus known to cause AIDS, but because they show that the virus already had an extensive amount of genetic diversity in 1960. [33]

In 2000, the Royal Society held a meeting to discuss data on the origin of AIDS; the OPV AIDS hypothesis was a central topic of discussion. At this meeting, three independent labs released the results of tests on the remaining stocks of Koprowski's vaccine, which Edward Hooper had demanded in The River. The tests confirmed Koprowski's contention that his vaccine was made from monkey, rather than chimpanzee, kidney, and found no evidence of SIV or HIV contamination. Additional epidemiologic and phylogenetic data was presented at the conference which undermined other aspects of the OPV AIDS hypothesis. According to a report in Science, [34] Hooper "did not challenge the results; he simply dismissed them."

In 2001, three articles published in Nature examined various aspects of the OPV AIDS hypothesis, as did an article published in Science . In every case, the studies' findings argued strongly against any link between the polio vaccine and AIDS. [35] [36] [37] [38] The evidence cited included multiple independent studies that dated the introduction of HIV-1 to humans as occurring between 1915 and 1941, probably in the 1930s. [39] [40] [41] These results were confirmed by a later study using samples from the 1960s that also found that the epidemic began between 1908 and 1930, [42] [43] and a study that showed that although recombination amongst viruses makes dating less precise, it does not significantly bias estimates in either direction (it does not introduce a systematic error). [44]

The author of one of the studies, evolutionary biologist Edward Holmes of Oxford University, commented in light of the new evidence: "Hooper's evidence was always flimsy, and now it's untenable. It's time to move on." [3] An accompanying editorial in Nature concluded:

The new data may not convince the hardened conspiracy theorist who thinks that contamination of OPV by chimpanzee virus was subsequently and deliberately covered up. But those of us who were formerly willing to give some credence to the OPV hypothesis will now consider that the matter has been laid to rest. [45]

The possibility that chimpanzees found near Kisangani in the Democratic Republic of Congo (formerly Stanleyville) were, indirectly, the true source of HIV-1 was directly addressed in a 2004 study published in Nature. Here, the authors found that while SIV was present in chimpanzees in the area, the strain of SIV infecting these chimpanzees was phylogenetically distinct from all strains of HIV, providing direct evidence that these particular chimps were not the source of HIV in humans. [5]

Current oral polio-vaccine campaign in Africa

Rumours that polio vaccines are unsafe disrupted the longstanding effort of the WHO and UN to achieve poliomyelitis eradication worldwide through use of the oral polio vaccine of Albert Sabin, which is thought to be safe and effective by virtually all medical authorities. If this long-term public-health goal could be achieved, poliomyelitis would follow smallpox as the second eradicated infectious human disease. The OPV AIDS hypothesis relates only to the historical origin of AIDS, and its proponents have accepted the safety of the modern polio vaccines, but rumors based on a misunderstanding of the hypothesis exist, [46] [47] and those rumors are blamed in part for the recent failure to eliminate polio in Nigeria. [48]

By 2003, cases of poliomyelitis had been reduced to just a small number in isolated regions of West Africa, with sporadic cases elsewhere. However, the disease has since resurged in Nigeria and in several other nations of Africa, which epidemiologists trace to refusals by certain local populations to allow their children to be administered the Sabin oral vaccine. The expressed concerns of local populations often relate to fears that the vaccine might induce sterility, [49] and it seems [ according to whom? ] that debate over the OPV AIDS hypothesis has fueled additional fears. [50] Since 2003, these fears have spread among some in the Muslim community, with Datti Ahmed, of the Supreme Council for Sharia in Nigeria stating that:

We believe that modern-day Hitlers have deliberately adulterated the oral polio vaccines with anti-fertility drugs and viruses which are known to cause HIV and AIDS. [48]

As evidence to the success of polio eradication efforts, the vaccine-derived polioviruses (cVDPVs) nowadays cause more cases of polio paralysis than the wild type virus itself in many places, such as the Congo. [51] Polio has also resurged in areas of Pakistan, India and Bangladesh. [52] [53]

See also

Related Research Articles

<span class="mw-page-title-main">Polio</span> Infectious disease caused by poliovirus

Poliomyelitis, commonly shortened to polio, is an infectious disease caused by the poliovirus. Approximately 75% of cases are asymptomatic; mild symptoms which can occur include sore throat and fever; in a proportion of cases more severe symptoms develop such as headache, neck stiffness, and paresthesia. These symptoms usually pass within one or two weeks. A less common symptom is permanent paralysis, and possible death in extreme cases. Years after recovery, post-polio syndrome may occur, with a slow development of muscle weakness similar to that which the person had during the initial infection.

Various fringe theories have arisen to speculate about purported alternative origins for the human immunodeficiency virus (HIV) and the acquired immunodeficiency syndrome (AIDS), with claims ranging from it being due to accidental exposure to supposedly purposeful acts. Several inquiries and investigations have been carried out as a result, and each of these theories has consequently been determined to be based on unfounded and/or false information. HIV has been shown to have evolved from or be closely related to the simian immunodeficiency virus (SIV) in West Central Africa sometime in the early 20th century. HIV was discovered in the 1980s by the French scientist Luc Montagnier. Before the 1980s, HIV was an unknown deadly disease.

<span class="mw-page-title-main">Polio vaccine</span> Vaccine to prevent poliomyelitis

Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization (WHO) recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018.

<span class="mw-page-title-main">Poliovirus</span> Enterovirus

Poliovirus, the causative agent of polio, is a serotype of the species Enterovirus C, in the family of Picornaviridae. There are three poliovirus serotypes: types 1, 2, and 3.

<span class="mw-page-title-main">John Franklin Enders</span> American medical researcher (1897-1985)

John Franklin Enders was an American biomedical scientist and Nobel Laureate. Enders has been called "The Father of Modern Vaccines."

<span class="mw-page-title-main">Albert Sabin</span> Medical researcher

Albert Bruce Sabin was a Polish-American medical researcher, best known for developing the oral polio vaccine, which has played a key role in nearly eradicating the disease. In 1969–72, he served as the president of the Weizmann Institute of Science in Israel.

<span class="mw-page-title-main">Hilary Koprowski</span> Polish-Jewish-American physician, virologist, immunologist and medical researcher

Hilary Koprowski was a Polish virologist and immunologist active in the United States who demonstrated the world's first effective live polio vaccine. He authored or co-authored over 875 scientific papers and co-edited several scientific journals.

<span class="mw-page-title-main">Pulse Polio</span> Indian governmental immunisation campaign

Pulse Polio is an immunisation campaign established by the government of India to eliminate poliomyelitis (polio) in India by vaccinating all children under the age of five years against the polio virus. The project fights polio through a large-scale, pulse vaccination programme and monitoring for poliomyelitis cases.

<span class="mw-page-title-main">H. R. Cox</span>

Herald Rea Cox (1907–1986) was an American bacteriologist. The bacterial family Coxiellaceae and the genus Coxiella, which include the organism that causes Q fever, are named after him.

Cutter Laboratories was a family-owned pharmaceutical company located in Berkeley, California, founded by Edward Ahern Cutter in 1897. Cutter's early products included anthrax vaccine, hog cholera virus, and anti-hog cholera serum—and eventually a hog cholera vaccine. The hog cholera vaccine was the first tissue culture vaccine, human or veterinary, ever produced. The company expanded considerably during World War II as a consequence of government contracts for blood plasma and penicillin. After Edward Cutter's death, his three sons—Dr. Robert K. Cutter (president), Edward "Ted" A. Cutter Jr. (vice-president), and Frederick A. Cutter—ran the company. In the next generation Robert's son David followed his father as president of the company. The Bayer pharmaceutical company bought Cutter Laboratories in 1974.

<span class="mw-page-title-main">Polio eradication</span> Effort to permanently eliminate all cases of poliomyelitis infection

Polio eradication, the permanent global cessation of circulation of the poliovirus and hence elimination of the poliomyelitis (polio) it causes, is the aim of a multinational public health effort begun in 1988, led by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF) and the Rotary Foundation. These organizations, along with the U.S. Centers for Disease Control and Prevention (CDC) and The Gates Foundation, have spearheaded the campaign through the Global Polio Eradication Initiative (GPEI). Successful eradication of infectious diseases has been achieved twice before, with smallpox in humans and rinderpest in ruminants.

<span class="mw-page-title-main">History of polio</span> History of poliomyelitis infections

The history of polio (poliomyelitis) infections began during prehistory. Although major polio epidemics were unknown before the 20th century, the disease has caused paralysis and death for much of human history. Over millennia, polio survived quietly as an endemic pathogen until the 1900s when major epidemics began to occur in Europe. Soon after, widespread epidemics appeared in the rest of the world. By 1910, frequent epidemics became regular events throughout the developed world primarily in cities during the summer months. At its peak in the 1940s and 1950s, polio would paralyze or kill over half a million people worldwide every year.

An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable. Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the pathogen.

<span class="mw-page-title-main">Isabel Morgan</span> American virologist

Isabel Merrick Morgan was an American virologist at Johns Hopkins University, who prepared an experimental vaccine that protected monkeys against polio in a research team with David Bodian and Howard A. Howe. Their research led to the identification of three distinct serotypes of poliovirus, all of which must be incorporated for a vaccine to provide complete immunity from poliomyelitis. Morgan was the first to successfully use a killed-virus for polio inoculation in monkeys. After she married in 1949, she left the field of polio research in part because she was uncomfortable with trials that tested polio vaccines on the nerve tissue of children. She then worked on epidemiological studies on air pollution. Later in life, she was a consultant for studies of cancer therapies at the Sloan-Kettering Cancer Institute.

<span class="mw-page-title-main">David Bodian</span> American medical scientist (1910–1992)

David Bodian was an American medical scientist at the Johns Hopkins University School of Medicine who worked in polio research. In the early 1940s he helped lay the groundwork for the eventual development of polio vaccines by combining neurological research with the study of the pathogenesis of polio. With his understanding of the disease, he made a series of crucial discoveries that paved the way for the final development of a vaccine by Jonas Salk and later by Albert Sabin. He received the E. Mead Johnson Award in Pediatrics and the Karl Spencer Lashley Award for his work, along with numerous other distinctions.

Mikhail Petrovich Chumakov was a Soviet Russian microbiologist and virologist most famous for conducting pivotal large-scale clinical trials that led to licensing of the Oral Polio Vaccine (OPV) developed by Albert B. Sabin.

Vaccine shedding is a form of viral shedding which can occasionally occur following a viral infection caused by an attenuated vaccine. Illness in others resulting from transmission through this type of viral shedding is rare. Most vaccines are not attenuated vaccines, and therefore cannot cause vaccine-induced viral shedding, though the idea of shedding is a popular anti-vaccination myth.

DTaP-IPV-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated polio vaccine or DTaP-IPV-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and hepatitis B.

Marina Konstantinovna Voroshilova was a Soviet virologist and corresponding member of the Academy of Medical Sciences of the USSR (1969). She is best known for her work on the introduction of vaccines against poliomyelitis, the discovery of non-specific effects of oral poliovirus vaccine (OPV), and developing the concept of beneficial human viruses.

References

  1. ↑ Hillis DM (2000). "AIDS. Origins of HIV". Science. 288 (5472): 1757–1759. doi:10.1126/science.288.5472.1757. PMID   10877695. S2CID   83935412.
  2. ↑ Birmingham K (2000). "Results make a monkey of OPV-AIDS theory". Nat Med. 6 (10): 1067. doi: 10.1038/80356 . PMID   11017114. S2CID   10860468.
  3. 1 2 Cohen J (2001). "AIDS origins. Disputed AIDS theory dies its final death". Science. 292 (5517): 615a–615. doi:10.1126/science.292.5517.615a. PMID   11330303. S2CID   70625478.
  4. ↑ "Origin of Human Immunodeficiency Virus (HIV/AIDS)". Centers for Disease Control and Prevention. 22 October 2007. Archived from the original on 25 February 2008. Retrieved 1 May 2021.
  5. 1 2 Worobey M, Santiago M, Keele B, Ndjango J, Joy J, Labama B, Dhed'A B, Rambaut A, Sharp P, Shaw G, Hahn B (2004). "Origin of AIDS: contaminated polio vaccine theory refuted". Nature. 428 (6985): 820. Bibcode:2004Natur.428..820W. doi: 10.1038/428820a . PMID   15103367. S2CID   4418410.
  6. 1 2 Kew O, Sutter R, de Gourville E, Dowdle W, Pallansch M (2005). "Vaccine-derived polioviruses and the endgame strategy for global polio eradication". Annu Rev Microbiol. 59 (1): 587–635. doi:10.1146/annurev.micro.58.030603.123625. PMID   16153180.
  7. ↑ Pearce J (2004). "Salk and Sabin: poliomyelitis immunisation". J Neurol Neurosurg Psychiatry. 75 (11): 1552. doi:10.1136/jnnp.2003.028530. PMC   1738787 . PMID   15489385.
  8. 1 2 Furesz J (2006). "Developments in the production and quality control of poliovirus vaccines – Historical perspectives". Biologicals. 34 (2): 87–90. doi:10.1016/j.biologicals.2006.02.008. PMID   16621594.
  9. 1 2 3 Plotkin SA; Modlin, J. F.; Plotkin, S. A. (2001). "CHAT oral polio vaccine was not the source of human immunodeficiency virus type 1 group M for humans". Clin. Infect. Dis. 32 (7): 1068–1084. doi: 10.1086/319612 . PMID   11264036.
  10. ↑ Koprowski H (July 1960). "Historical aspects of the development of live virus vaccine in poliomyelitis". Br Med J. 2 (5192): 85–91. doi:10.1136/bmj.2.5192.85. PMC   2096806 . PMID   14410975.
  11. ↑ Plotkin SA, LeBrun A, Koprowski H (1960). "Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville. Belgian Congo 2. Studies of the safety and efficacy of vaccination" (PDF). Bull World Health Organ. 22 (3–4): 215–34. PMC   2555322 . PMID   14433516. Archived from the original (PDF) on 6 February 2012. Retrieved 30 January 2019.
  12. ↑ Plotkin SA, LeBrun A, Courtois G, Koprowski H (1961). "Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville, Congo 3. Safety and efficacy during the first 21 months of study" (PDF). Bull World Health Organ. 24 (6): 785–92. PMC   2555526 . PMID   13736381. Archived from the original (PDF) on 6 February 2012. Retrieved 30 January 2019.
  13. ↑ Enders, John (1955). "The present status of tissue-culture techniques in the study of poliomyelitis viruses" (PDF). In Debré, R. (ed.). Poliomyelitis. Geneva: World Health Organization. pp. 269–94. Archived from the original (PDF) on 6 February 2012. Retrieved 30 January 2019.
  14. ↑ Rappaport, Catherine (1956). "Trypsinization of Monkey-Kidney Tissue: Automatic Method for the Preparation of Cell Suspensions" (PDF). Bull World Health Organ. 14 (1): 147–66. PMC   2538109 . PMID   13329843. Archived from the original (PDF) on 6 February 2012. Retrieved 30 January 2019.
  15. ↑ Melnick, JL (1956) "Tissue culture methods for the cultivation of poliomyelitis and other viruses", in American Public Health Association, Diagnostic Procedures for Virus and Rickettsial Diseases 2nd ed., New York, pp. 97–151
  16. ↑ Rhodes AJ, Wood W, Duncan D (1955). "The present place of virus laboratory tests in the diagnosis of poliomyelitis, with special reference to tissue-culture techniques" (PDF). In Debré, R. (ed.). Poliomyelitis. Geneva: World Health Organization. Archived from the original (PDF) on 6 February 2012. Retrieved 30 January 2019.237–67
  17. 1 2 3 4 Plotkin SA (2001). "Untruths and consequences: the false hypothesis linking CHAT type 1 polio vaccination to the origin of human immunodeficiency virus". Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 (1410): 815–823. doi:10.1098/rstb.2001.0861. PMC   1088471 . PMID   11405925.
  18. ↑ Curtis, Tom (19 March 1992). "The Origin of AIDS: A startling new theory attempts to answer the question, 'Was it an act of God or an act of man?". No. 626. Rolling Stone. pp. 54–9, 61, 106, 108.
  19. ↑ "'Origin of AIDS' update – Clarification". Rolling Stone . No. 671. 9 December 1993. p. 39. This 'Clarification' article forms part of the defamation settlement when Hilary Koprowski sued Tom Curtis and Rolling Stone magazine in 1992–93.
  20. ↑ Martin B (August 2003). "Investigating the origin of AIDS: some ethical dimensions". J Med Ethics. 29 (4): 253–256. doi:10.1136/jme.29.4.253. PMC   1733782 . PMID   12930866.
  21. 1 2 Bliss, Mary (6 January 2001). "Origin of AIDS". The Lancet . 357 (9249): 73–4. doi: 10.1016/S0140-6736(05)71578-6 . PMID   11197392. S2CID   263972.
  22. 1 2 3 "The Politics of a Scientific Meeting: the Origin-of-AIDS Debate at the Royal Society". Politics and the Life Sciences . 20 (20). September 2001. Retrieved 1 September 2020.
  23. ↑ "Scientists started Aids epidemic". BCC News. 1 September 1999. Retrieved 1 September 2020.
  24. 1 2 Bozzi, Maria Luisa (29 September 2001). "Truth and Science: Bill Hamilton's Legacy" (PDF). Retrieved 1 September 2020.
  25. ↑ Plotkin SA, Teuwen DE, Prinzie A, Desmyter J (2001). "Postscript relating to new allegations made by Edward Hooper at The Royal Society Discussion Meeting on 11 September 2000". Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 (1410): 825–829. doi:10.1098/rstb.2001.0875. PMC   1088472 . PMID   11405926.
  26. ↑ Koprowski H (2001). "Hypotheses and facts". Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 (1410): 831–833. doi:10.1098/rstb.2001.0869. PMC   1088473 . PMID   11405927.
  27. ↑ Cecil Fox. "The Origins of AIDS (2004) video". YouTube .
  28. ↑ "Les origines du SIDA". IMDb . 2 May 2004.
  29. ↑ Osterrieth PM (June 2001). "Vaccine could not have been prepared in Stanleyville". Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 (1410): 839. doi:10.1098/rstb.2001.0872. PMC   1088475 . PMID   11405929.
  30. ↑ Osterrieth P (May 2004). "Oral polio vaccine: fact versus fiction". Vaccine. 22 (15–16): 1831–1835. doi:10.1016/j.vaccine.2004.01.028. PMID   15121291.
  31. ↑ Koprowski (1992). "AIDS and the Polio Vaccine". Science. 257 (5073): 1024–1027. Bibcode:1992Sci...257.1024K. doi:10.1126/science.257.5073.1024. PMID   1509249.
  32. ↑ "Panel nixes Congo trials as AIDS source". Science. 258 (5083): 738–9. 1992. doi:10.1126/science.258.5083.738-d. PMID   1439779.
  33. ↑ Worobey, Michael; Gemmel, Marla; Teuwen, Dirk E; Haselkorn, T; Kunstman, Kevin; Bunce, Michael; Muyembe, Jean-Jacques; Kabongo, Jean-Marie; Kalengayi, Raphael M; Van Marck, Eric; Gilbert, M Thomas P; Wolinsky, Steven M (2 October 2008). "Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960". Nature. 455 (7213): 661–4. Bibcode:2008Natur.455..661W. doi:10.1038/nature07390. PMC   3682493 . PMID   18833279.
  34. ↑ Cohen, Jon (12 September 2000). "Vaccine Theory of AIDS Takes a Blow". Science. Retrieved 6 November 2015.
  35. ↑ Blancou P, Vartanian J, Christopherson C, Chenciner N, Basilico C, Kwok S, Wain-Hobson S (2001). "Polio vaccine samples not linked to AIDS". Nature. 410 (6832): 1045–1046. Bibcode:2001Natur.410.1045B. doi: 10.1038/35074171 . PMID   11323657. S2CID   4419153.
  36. ↑ Berry N, Davis C, Jenkins A, Wood D, Minor P, Schild G, Bottiger M, Holmes H, Almond N (2001). "Vaccine safety. Analysis of oral polio vaccine CHAT stocks". Nature. 410 (6832): 1046–1047. Bibcode:2001Natur.410.1046B. doi: 10.1038/35074176 . PMID   11323658. S2CID   4387631.
  37. ↑ Rambaut A, Robertson DL, Pybus OG, Peeters M, Holmes EC (2001). "Human immunodeficiency virus. Phylogeny and the origin of HIV-1". Nature. 410 (6832): 1047–1048. Bibcode:2001Natur.410.1047R. doi:10.1038/35074179. PMID   11323659. S2CID   4353162.
  38. ↑ Poinar H, Kuch M, Pääbo S (2001). "Molecular analyses of oral polio vaccine samples". Science. 292 (5517): 743–744. Bibcode:2001Sci...292..743P. doi:10.1126/science.1058463. PMID   11326104. S2CID   24976042.
  39. ↑ Korber B, Muldoon M, Theiler J, et al. (2000). "Timing the ancestor of the HIV-1 pandemic strains". Science. 288 (5472): 1789–96. Bibcode:2000Sci...288.1789K. doi:10.1126/science.288.5472.1789. PMID   10846155.
  40. ↑ Salemi M, Strimmer K, Hall WW, et al. (2001). "Dating the common ancestor of SIVcpz and HIV-1 group M and the origin of HIV-1 subtypes using a new method to uncover clock-like molecular evolution". FASEB J. 15 (2): 276–8. doi: 10.1096/fj.00-0449fje . PMID   11156935. S2CID   35457733.
  41. ↑ Sharp PM, Bailes E, Chaudhuri RR, Rodenburg CM, Santiago MO, Hahn BH (2001). "The origins of acquired immune deficiency syndrome viruses: where and when?". Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 (1410): 867–876. doi:10.1098/rstb.2001.0863. PMC   1088480 . PMID   11405934.
  42. ↑ Worobey M, Gemmel M, Teuwen DE, et al. (October 2008). "Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960". Nature. 455 (7213): 661–4. Bibcode:2008Natur.455..661W. doi:10.1038/nature07390. PMC   3682493 . PMID   18833279.
  43. ↑ "News Africa". Reuters.com. Archived from the original on 5 October 2008. Retrieved 5 October 2008.
  44. ↑ Lemey P, Pybus OG, Rambaut A, et al. (July 2004). "The molecular population genetics of HIV-1 group O". Genetics. 167 (3): 1059–68. doi:10.1534/genetics.104.026666. PMC   1470933 . PMID   15280223.
  45. ↑ Weiss RA (2001). "Polio vaccines exonerated". Nature. 410 (6832): 1035–1036. Bibcode:2001Natur.410.1035W. doi: 10.1038/35074222 . PMID   11323649. S2CID   5491605.
  46. ↑ "Nigeria Muslims oppose polio vaccination". BBC News. 27 June 2002. Retrieved 1 May 2021.
  47. ↑ Dugger, Celia W.; McNeil Jr., Donald G. (20 March 2006). "Rumor, Fear and Fatigue Hinder Final Push to End Polio". The New York Times. Retrieved 1 May 2021.
  48. 1 2 Jegede AS (2007). "What led to the Nigerian boycott of the polio vaccination campaign?". PLOS Med. 4 (3): e73. doi: 10.1371/journal.pmed.0040073 . PMC   1831725 . PMID   17388657.
  49. ↑ "Anti-polio vaccine Malians jailed". BBC News. 12 May 2005. Retrieved 1 May 2021.
  50. ↑ Cohen, Jon (2000) Atlantic Monthly (Oct), p. 104.
  51. ↑ Roberts, Leslie (2 July 2018). "Alarming polio outbreak spreads in Congo, threatening global eradication efforts". Science | AAAS. Retrieved 15 January 2021.
  52. ↑ Global Polio Eradication Initiative (2007) map of last six months of polio cases worldwide Wild Poliovirus Weekly Update initiative of WHO, CDC, UNICEF, Rotary International online Archived 25 September 2006 at archive.today
  53. ↑ "Bangladesh begins new polio drive". BBC News. 2 March 2007. Retrieved 1 May 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.